Difference between revisions of "MitoFit Workshop Blood Cells 2016-01-08"
From Bioblast
Line 29: | Line 29: | ||
* Blood cell mitochondria for drug development. | * Blood cell mitochondria for drug development. | ||
* Perspectives for the stakeholders. Β | * Perspectives for the stakeholders. Β | ||
Line 53: | Line 37: | ||
! Participant | ! Participant | ||
! Institution | ! Institution | ||
|- | |||
|[[Baptista Ramon B]] | |||
|'''[[BR Manaus Val AL]]:''' Instituto Nacional de Pesquisas de Amazonia (BR) | |||
|- | |- | ||
|[[Calabria Elisa]] | |[[Calabria Elisa]] | ||
Line 74: | Line 61: | ||
|[[Mutschler Rainer]] | |[[Mutschler Rainer]] | ||
|'''DE Speyer Mutschler R:''' BioMedical Center Speyer, Center for Integrative Medicine (DE) | |'''DE Speyer Mutschler R:''' BioMedical Center Speyer, Center for Integrative Medicine (DE) | ||
|- | |- | ||
|[[Hagl Stephanie]] | |[[Hagl Stephanie]] |
Revision as of 14:47, 7 January 2016
MitoFit Workshop Blood Cells 2016-01-08
Innsbruck AT, 2016 Jan 08. MitoFit Workshop on blood cell respirometry for mitochondrial research and diagnostic applications. |
OROBOROS (2016-01-08) Mitochondr Physiol Network
Abstract:
MitoFit Workshop on blood cell respirometry for mitochondrial research and diagnostic applications. Innsbruck, AT
β’ O2k-Network Lab: AT Innsbruck OROBOROS
Topics
The following topics will be addressed:
- Standardization of blood sampling.
- Standard protocols for blood cell separation, cell type characterization (purity, composition).
- Measurements for normalization: cell counting, protein, marker enzymes.
- Blood cells storage: from fresh cells to cryopreservation.
- Incubation media for measurement of intact and permeabilized cells.
- Respiratory SUIT protocols: From replicates to multiple SUIT protocols.
- Quality control, data analysis and data reporting.
- Towards a data bank on mitochondrial respiratory function in human blood cells.
- Mitochondrial biomarker: correlations of mitochondrial function in blood cells and other tissues.
- From mitochondrial research to personalized patient diagnostics.
- Blood cell mitochondria for drug development.
- Perspectives for the stakeholders.
Participants
Participant | Institution |
---|---|
Baptista Ramon B | BR Manaus Val AL: Instituto Nacional de Pesquisas de Amazonia (BR) |
Calabria Elisa | IT Verona Capelli C: Department of Neurological and Movement Sciences, University of Verona (IT) |
Doerrier Carolina | AT Innsbruck OROBOROS: OROBOROS INSTRUMENTS (AT) |
Gnaiger Erich | AT Innsbruck OROBOROS: D. Swarovski Research Laboratory, Medical University of Innsbruck and OROBOROS INSTRUMENTS (AT) |
Khalid Sana | AT Innsbruck Gnaiger E: D. Swarovski Research Laboratory, Medical University of Innsbruck (AT) |
Krumschnabel Gerhard | AT Innsbruck OROBOROS: OROBOROS INSTRUMENTS (AT) |
Lamberti Giorgia | AT Innsbruck OROBOROS: OROBOROS INSTRUMENTS (AT) |
Mutschler Rainer | DE Speyer Mutschler R: BioMedical Center Speyer, Center for Integrative Medicine (DE) |
Hagl Stephanie | DE Frankfurt Eckert GP: Pharmakologisches Institut fΓΌr Naturwissenschaftler, Biozentrum Campus Riedberg, Frankfurt am Main (DE) |
Sumbalova Zuzana | AT Innsbruck OROBOROS: OROBOROS INSTRUMENTS (AT) |
Zischka Hans | DE Munich Zischka H: Institute of Molecular Toxicology and Pharmacology, Helmholtz Zentrum MΓΌnchen (DE) |
Literature
The growing number of blood cell mito publications: O2k-Publications - Blood cells
Labels:
ORO, 2016, O2k-Network, MitoFit, Next